Standout Papers

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS... 2003 2026 2010 2018 544
  1. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial (2003)
    John Zajicek, Patrick J. Fox et al. The Lancet
  2. Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis (2014)
    Stephen H. Gillespie, Angela M. Crook et al. New England Journal of Medicine
  3. A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis (2019)
    Andrew Nunn, Patrick Phillips et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 8 from Science/Nature 71 standout
Sub-graph 1 of 20

Citing Papers

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis
2022 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
1 intermediate paper

Works of Andrew Nunn being referenced

A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis
2019 Standout
Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (PREDICT): a 12-month, multicentre, randomised trial
2014

Author Peers

Author Last Decade Papers Cites
Andrew Nunn 4691 3335 1975 238 11.2k
Mark Loeb 4566 6020 2040 333 15.8k
Heiner C. Bucher 2764 3731 1168 253 14.6k
Stephen M. Graham 4812 4008 774 323 11.5k
Álvaro Muñoz 3810 4967 862 234 14.4k
Mary Cheang 1779 4857 1089 132 11.9k
Steven M. Teutsch 1816 2522 972 150 12.8k
Brian L. Strom 1342 2532 1241 278 14.6k
Shahnaz Sultan 1925 2395 2000 168 12.2k
Rebecca L. Morgan 2374 3009 861 175 10.9k
Bruce Fireman 1726 6996 2322 251 16.4k

All Works

Loading papers...

Rankless by CCL
2026